LEO Pharma initiates phase IIa study of LEO-152020 in cholinergic urticaria June 16, 2021 No Comments
Aclaris reports topline phase IIa data on ATI-1777 in moderate to severe atopic dermatitis June 9, 2021 No Comments
Sonelokimab shows significant clinical benefit over placebo in patients with plaque psoriasis May 26, 2021 No Comments
Olix initiates phase II study of OLX-10010 as treatment of hypertrophic scars May 21, 2021 No Comments
RSS